About this role
About Collate
Collate is an AI document generation platform for life sciences. We automate paperwork with AI, helping our customers get life-saving innovations to patients years faster. Collate is an end-to-end solution, powering every step of drug, diagnostic, and medical device development—from concept to market.
Our CEO Surbhi Sarna is a former General Partner at Y Combinator. Surbhi founded nVision Medical, which developed a new method to detect ovarian cancer and was acquired by Boston Scientific. Our CTO Nate Smith is a former Visiting Partner at Y Combinator and founder of Lever. Our AI researchers, engineers, and designers have worked at Google, Nvidia, Meta, Netflix, Amazon, AirBnB, Hippocratic AI, and Grail, and 40% of our team are former founders.
We’re an elite team, with $125M in funding from top investors (Redpoint, First Round Capital, CRV, Conviction, Y Combinator) and leaders in healthcare and AI. This is a rare chance to join an early-stage company with world-changing potential, experienced founders, and resources to execute at scale.
About the Role
Collate is the first of its kind for what we're building — no incumbent doing this today, and no established workflow to copy. That's the job: continue to define the roadmap for an AI category that doesn't exist yet, then build it.
You'll co-own the product surface end to end that lets the world's most regulated companies trust us with their most sensitive documents. You'll sit at the intersection of engineering and go-to-market, working directly with Surbhi (CEO) to turn what customers need into a roadmap the team can actually ship.
This is a rare seat: you're not maintaining an AI category, you're creating a new one. It's a role for someone who wants outsized ownership over how an early-stage company becomes the category leader without slowing down.
We are 5 days a week onsite in San Francisco.